The effector domain of Rab6, plus a highly hydrophobic C terminus, is required for Golgi apparatus localization by Beranger,  F. et al.
  
1994, 14(1):744. DOI: 10.1128/MCB.14.1.744. Mol. Cell. Biol. 
Hancock
F Beranger, H Paterson, S Powers, J de Gunzburg and J F
 
apparatus localization.
hydrophobic C terminus, is required for Golgi 
The effector domain of Rab6, plus a highly
http://mcb.asm.org/content/14/1/744
Updated information and services can be found at: 
These include:
CONTENT ALERTS
 more»cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new articles
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 February 25, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
 o
n
 February 25, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY, Jan. 1994, p. 744-758 Vol. 14, No. 1
0270-7306/94/$04.00+0
Copyright X 1994, American Society for Microbiology
The Effector Domain of Rab6, Plus a Highly Hydrophobic C
Terminus, Is Required for Golgi Apparatus Localization
FLORENCE BERANGER,1 HUGH PATERSON,2 SCOTT POWERS,3 JEAN DE GUNZBURG,l
AND JOHN F. HANCOCK3*
INSERM Unite 248, Faculte de Medecine Lariboisiere-St. Louis, 75010 Paris, France';
Institute of Cancer Research, Chester Beatty Laboratories, London SW3, England2;
and ONYX Pharmaceuticals, Richmond, California 948063
Received 11 June 1993/Returned for modification 29 July 1993/Accepted 4 October 1993
C-terminal lipid modifications are essential for the interaction of Ras-related proteins with membranes.
While all Ras proteins are farnesylated and some palmitoylated, the majority of other Ras-related proteins are
geranylgeranylated. One such protein, Rab6, is associated with the Golgi apparatus and has a C-terminal CXC
motif that is geranylgeranylated on both cysteines. We show here that farnesylation alone cannot substitute for
geranylgeranylation in targeting Rab6 to the Golgi apparatus and that whereas Ras proteins that are
farnesylated and palmitoylated are targeted to the plasma membrane, mutant Rab proteins that are both
farnesylated and palmitoylated associate with the Golgi apparatus. Using chimeric Ras-Rab proteins, we find
that there are sequences in the N-terminal 71 amino acids of Rab6 which are required for Golgi complex
localization and show that these sequences comprise or include the effector domain. The C-terminal
hypervariable domain is not essential for the Golgi complex targeting of Rab6 but is required to prevent
prenylated and palmitoylated Rab6 from localizing to the plasma membrane. Functional analysis of these
mutant Rab6 proteins in Saccharomyces cerevisiae shows that wild-type Rab6 and C-terminal mutant Rab6
proteins which localize to the Golgi apparatus in mammalian cells can complement the temperature-sensitive
phenotype ofypt6 null mutants. Interestingly, therefore, the C-terminal hypervariable domain of Rab6 is not
required for this protein to function in S. cerevisiae.
Ras-related proteins are 21- to 25-kDa proteins which bind
guanine nucleotides and have GTPase activity. On the basis
of their sequence homology, they can be divided into three
main subfamilies: Ras, Rho, and Rab (13). All operate as
molecular switches by interacting with different sets of
proteins in the inactive GDP- or active GTP-bound state
(reviewed in reference 8). Ras-related proteins are involved
in regulating a wide range of cellular processes, including
cell proliferation, differentiation, intracellular trafficking (7,
24), membrane ruffling, and assembly of actin stress fibers
(43, 44). Although these proteins serve very diverse func-
tions, their ability to associate with cell membranes is a
fundamental requirement for biological activity (review in
reference 20) such that mutations in Ras, Rho, and Rab
proteins which block membrane localization also render
these proteins biologically inactive (2, 21, 40, 49, 51).
The mechanism of attachment of Ras proteins to the inner
surface of the plasma membrane provides a model for the
membrane targeting of other Ras-related proteins. The C
terminus of Ras terminates in a CAAX motif (C = cysteine,
A = aliphatic amino acid, X = any amino acid) which
undergoes farnesylation of the cysteine residue (12, 28),
proteolysis by an endopeptidase to remove the AAX amino
acids (19, 23), and carboxyl-methyl esterification of the
cysteine (16, 23). Although these modifications render the C
terminus of the protein hydrophobic and thereby facilitate
membrane association, additional protein sequences in the
adjacent C-terminal hypervariable region are required to
target Ras proteins to the plasma membrane. This second
* Corresponding author. Mailing address: ONYX Pharmaceuti-
cals, 3031 Research Dr., Richmond, CA 94806. Phone: (510) 222
9700. Fax: (510) 222 9758.
signal is a polylysine domain in K-Ras and cysteine palmi-
toylation sites in the H- and N-Ras proteins. This combina-
tion of CAAX motif plus a second signal is also sufficient to
target cytosolic heterologous proteins, such as protein A (25)
or p120 GTPase-activating protein (GAP) (34), to the plasma
membrane.
It is interesting to note that while Ras proteins are farne-
sylated, the majority of other Ras-related proteins are gera-
nylgeranylated (reviewed in reference 29). Alkylation with
C20 geranylgeranyl occurs on proteins with three different
C-terminal motifs; CAAX motifs, where X is a leucine or a
phenylalanine, are prenylated by geranylgeranyltransferase I
(GGTase I) (11, 41, 47), and CC and CXC motifs, which are
found at the C termini of Rab proteins, are prenylated by
GGTase II, also known as Rab geranylgeranyltransferase
(32, 45, 46). Following geranylgeranylation, CAAL/F motifs
are AAX proteolysed and methylated. The CXC motif is
geranylgeranylated on both cysteines and is also methylated
(18, 42). The stoichiometry of geranylgeranylation of the CC
motif is less certain (20, 36, 38, 50). However, this motif is
not methylated (42, 50). It is reasonable to speculate that
there is a single C20 geranylgeranyl group attached to the
upstream cysteine, since a carboxy-terminal geranygeranyl
cysteine would be a substrate for methylation. The biological
significance of these different stoichiometries and different
methylation statuses is not known. The famesyltransferase
and GGTase I prenylate CAAX or CAAL tetrapeptides in
vitro, while the recognition sequence for Rab GGTase II is
more complex (35) and may involve Rab sequences remote
from the CC and CXC motifs.
Rab proteins are attached to different intracellular mem-
branes and are involved in endocytosis and secretion (9, 48).
The targeting of Rab proteins to specific subcellular loca-
tions is determined in part by their C-terminal sequences
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(14), but whether these sequences are sufficient to target
heterologous proteins to the same locations is unclear, and
the role played by geranylgeranylation in Rab localization
has not been investigated. An interesting question is whether
C15 (farnesol) and C20 (geranylgeranyl) moieties are inter-
changeable for Rab proteins. Such analysis of Ras has
yielded some interesting observations. First, Ras proteins
with an X-*L mutation in the CAAX box undergo gera-
nylgeranylation but are still localized to the plasma mem-
brane. However, if the polybasic domain or palmitoylation
site is removed, these geranylgeranylated Ras proteins are
associated with intracellular membranes and not the plasma
membrane (25). Geranylgeranylated oncogenic Ras proteins
are transforming irrespective of their subcellular localization
(25), but low-level expression of plasma membrane-localized
geranylgeranylated wild-type Ras is growth inhibitory (17).
The Rab6 protein is localized in the medial and trans
cisternae of the Golgi complex (22). The C-terminal CSC
sequence predicts prenylation with two geranylgeranyl
groups followed by methylation. We have constructed Rab6
proteins with a set of alternative C-terminal motifs (CC,
CCIL, CKCCIL, CVLS, and CKCVLS) to direct all known
combinations of C-terminal lipid modifications. Our results
show that farnesylation alone cannot substitute for gera-
nylgeranylation to localize Rab6 to the Golgi complex,
demonstrating a significant functional difference between
these isoprenoids. However, a combination of farnesylation
plus palmitoylation, which localizes heterologous proteins to
the plasma membrane, localized Rab6 to the Golgi complex.
We conclude that the Rab6 protein contains sequences
which can override the plasma membrane-targeting function
of this lipid combination and show that while these overrid-
ing sequences are contained within the C-terminal hypervari-
able domain of the protein, the Golgi-targeting sequence is
not. A functional analysis of mutant Rab6 proteins in Sac-
charomyces cerevisiae shows that suppression of the ypt6-
phenotype correlates with Golgi localization in mammalian
cells and that the C-terminal hypervariable domain of Rab6
is not required for function in yeast cells.
MATERIALS AND METHODS
Constructs. The C-terminal sequences used to construct
the mutant Rab6 proteins were synthesized by PCR, using as
the templates H-ras CCIL and H-ras CAIL mutant cDNAs,
which have CAAX motifs that direct geranylgeranylation
(described in reference 25), wild-type H-ras cDNA, and
wild-type rab6 cDNA (52). The PCR primers included novel
restriction sites for cloning that did not alter the coding
sequence. The PCR products were cloned into pGEM
9Zf(-) (Promega) for sequencing and subsequently cloned in
frame into the coding sequence of Rab6 in the eukaryotic
expression vector pEXV3. Other mutations were introduced
into appropriate templates by oligonucleotide-directed mu-
tagenesis, using a mutagenesis kit (Amersham International,
Amersham, England). The Myc epitope, cloned into the
bacterial expression vector ptrp-tag, was obtained from Alan
Hall (Chester Beatty Laboratories, London, England). The
coding sequence for MEQKLISEEDL was removed, and by
using PCR, a Kozak consensus sequence was introduced at
the 5' end to optimize eukaryotic expression. The modified
tag was cloned in frame onto the N terminus of rab6 and
resequenced, and this new Myc-tagged rab6 cDNA was used
to make other Myc-tagged constructs by simple recombina-
tion.
In vitro translation and isoprenoid analysis. Mutant and
wild-type rab6 cDNAs were cloned into pGEM vectors
(Promega), and mRNA was prepared by in vitro transcrip-
tion. Nuclease-treated rabbit reticulocyte lysate was ob-
tained from Promega, and translations were performed ac-
cording to the manufacturer's instructions. Reactions were
performed at 30°C for 90 min, using 2 p,g of uncapped RNA
in a reaction volume of 50 ,ul with 50 ,Ci of R [5-3H]meval-
onic acid (NET 716; NEN). The whole lysate was parti-
tioned in Triton X-114, and the detergent-partitioning frac-
tion was immunoprecipitated with anti-Rab6 antibodies.
Following sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE), the gel was soaked in Enlightening
(NEN) and autoradiographed. The labelled bands were
digested with pronase from gel slices that had been excised
using the autoradiogram as a guide. Labelled peptides were
cleaved with methyl iodide by the method of Casey et al. (12)
and analyzed by high-pressure liquid chromatography as
previously described (42).
COS cell expression and Triton X-114 partitioning. COS1
cells were electroporated by a method based on that of Chu
et al. (15). Cells were harvested 72 h after transfection and
fractionated as described previously (10) except that mem-
branes were pelleted at 120,000 x g for 30 min. For the
pulse-chase experiments, cells were incubated in methi-
onine-free Dulbecco modified Eagle medium (DMEM) for 1
h before being metabolically labelled for 10 min with 0.3 mCi
of Expres(5S) labelling mix (NEGO72; NEN) per ml in
methionine-free DMEM. Labelled cells were lysed immedi-
ately or chased for 6 or 24 h with unlabelled medium.
Alternatively, cells were labelled with 1 mCi of [3H]palmitic
acid (TRK760; Amersham) per ml for 4 h in DMEM contain-
ing 5 mM pyruvate (39). Cell lysates were prepared in 1%
Triton X-114 containing a cocktail of protease inhibitors
(leupeptin, soy bean trypsin inhibitor, and aprotinin), incu-
bated on ice for 10 min, and centrifuged at 4°C to remove
insoluble debris. The lysates were separated into aqueous
and detergent phases by being warmed to 37°C for 2 min and
then microcentrifuged for 2 min (6, 23). [3H]palmitic acid-
labelled samples were not phase separated. Aqueous and
detergent-enriched phases were either immunoprecipitated
with anti-Rab6 antibodies if radiolabelled or trichloroacetic
acid precipitated if not. Immunoprecipitations were carried
out as described previously (22), boiled in Laemmli sample
buffer, resolved by SDS-PAGE, fluorographed with Enlight-
ening (NEN), and exposed overnight at -70°C. For methy-
lation assays, COS cells were labelled for 18 h with 200 ,Ci
of [methyl-3H]methionine (NEN) per ml, and Rab proteins
were immunoprecipitated with anti-Rab6 antibodies. La-
belled Rab proteins were isolated from SDS-gels and sub-jected to alkaline hydrolysis as described previously (16, 23).
Western blotting (immunoblotting). Aqueous and deter-
gent-enriched phases of Triton X-114-partitioned, nonla-
belled COS1 cell lysates or equal proportions of S100 and
P100 fractions were precipitated with 10% trichloroacetic
acid on ice for 1 h. The precipitated proteins were collected
by centrifugation, washed three times with 1 ml of cold
acetone, dried, and taken up in Laemmli sample buffer (42).
Following SDS-PAGE, the proteins were transferred to
nitrocellulose by using a semidry blotting system (Pharma-
cia). The filter was blocked overnight in phosphate-buffered
saline (PBS) containing 0.1% Tween 20 (PBST) and 5% dried
milk (PBST+M) and then incubated for 1 h with anti-Myc
monoclonal antibody 9E10 diluted 1/4,000 in PBST+M.
After three washes with PBST, the filter was incubated for 1
h with an anti-mouse horseradish peroxidase conjugate
(NA931; Amersham) diluted 1/1000 in PBST+M, then
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746 BERANGER ET AL.
washed extensively, and developed by using an enhanced
chemiluminescence (ECL) detection kit (Amersham) ac-
cording to the manufacturer's instructions. Exposure times
on Hyperfilm-ECL (Amersham) ranged from 15 s to 10 min.
MDCK microinjection and immunofluorescence. MDCK
cells growing on glass coverslips were microinjected in the
nucleus with plasmid DNA at a concentration of 50 ,ug/ml.
After 18 h at 37°C, the cells were permeabilized with a
solution of 0.5% saponin-0.2% bovine serum albumin (BSA)
in PBS for 3 min and fixed in 4% formaldehyde in PBS for 20
min. The coverslips containing the fixed cells were washed
for 30 min in a solution of 0.05% saponin-0.2% BSA in PBS.
All further washes and incubations were also performed in
this solution. For detection of Myc-tagged proteins, the cells
were incubated in anti-Myc mouse monoclonal antibody
9E10 ascites fluid diluted 1:200 for 1 h and then in goat
fluorescein isothiocyanate-conjugated anti-mouse immuno-
globulin G second antibody (Pierce) diluted 1:500 for 1 h. For
detection of endogenous Rab6, cells were incubated in
affinity-purified polyclonal rabbit anti-Rab6 serum diluted
1:20 for 1 h and then in goat fluorescein isothiocyanate-
conjugated anti-rabbit immunoglobulin G second antibody(Pierce) diluted 1:1250 for 1 h. The coverslips were then
mounted in Moviol mountant containing 0.1% p-phenyldi-
amine and examined with a Bio-Rad MRC 600 confocal
imaging system in conjunction with a Nikon Optiphot fluo-
rescence microscope and 60x Planapo objective lens.
For brefeldin A experiments, Swiss 3T3 cells growing on
coverslips were microinjected in the nucleus with plasmid
DNA as described above. After 18 h at 37°C, cells were
either permeabilized, washed, and fixed as described above
or first incubated in brefeldin A at 5 ,ug/ml for 15 min before
permeabilization, washing, and fixation. Staining was car-
ried out as for MDCK cells.
Yeast methods. The ypt6 null mutant GL72 (A4T a
ypt6::LEU2 his3) (kindly provided by D. Gallwitz) was
crossed with a standard laboratory strain to obtain RS80-5A(MAT a ypt6::LEU2 ura3). RS80-5A was transformed with
wild-type and C-terminal mutant Rab6 yeast expression
plasmids. Wild-type and mutant Rab6 coding sequences
were transferred into the yeast expression vector pNV11,
which utilizes the TDH3 (glyceraldehyde-3-phosphate dehy-
drogenase) promoter (kindly provided by M. Ruggieri). For
each plasmid, four independent Ura+ transformants were
patched onto synthetic medium plates lacking uracil, grown
at the permissive temperature (30°C) for 1 day, and replica
plated onto synthetic medium plates, which were then incu-
bated at either 30 or 37.5°C. Complementation of the ypt6
null mutation was assessed by the ability of the plasmids to
restore growth at 37.5°C. For some transformants, growth at
37.5°C in liquid culture was monitored with a Klett colorim-
eter.
To study expression levels of mutant Rab proteins, 25-ml
cultures of each transformant, and RS80-5A as control, were
grown in synthetic medium with Ura+ selection at 30°C to a
density of 3 x 107 cells per ml. The yeast cells were collected
by centrifugation and resuspended in 500 p,u of PBS contain-
ing 1 mM dithiothreitol and 1 mM phenylmethylsulfonyl
fluoride. Glass beads were added, and the tubes were
vortexed six times for 30 s each time. The lysates were
clarified by centrifugation at 1,000 x g. Aliquots of each
lysate were precipitated with 95% acetone (final concentra-
tion), and the precipitated proteins were resolved by SDS-
PAGE. Western blotting was carried out with 9E10 as the
primary antibody.
RESULTS
Strategy for designing Rab6 proteins with mutant C ter-
mini. Wild-type Rab6 terminates in a C-terminal C1XC2
motif. This sequence has been shown previously to be
geranylgeranylated on both of the C1 and C2 cysteines by the
enzyme GGTase II. Following geranylgeranylation of the C2
cysteine, this residue is methyl esterified. To generate mu-
tant Rab6 proteins that had a different lipid combination at
the C terminus, we replaced the C-terminal CXC motif with
the sequence C1XC2AAL (where A = aliphatic amino acid
and L = leucine) to create a substrate for the enzyme
GGTase I, which recognizes the CAAL C-terminal motif.
Following geranylgeranylation of the C2 cysteine, the AAL
amino acids are removed by proteolysis and the C2 carboxyl
group is methylated. In the context of a prenylated, methy-
lated cysteine, the C1 cysteine is now an acylation site for
the palmitoyl coenzyme A transferase that palmitoylates the
Ras proteins. Thus, although completely different enzymes
modify the mutant Rab protein, the net effect is simply the
replacement of the C1 geranylgeranyl group with palmitate.
Similarly, a palmitoylated and famesylated Rab6 protein was
generated by replacing the CXC motif with a C1XC2AAX
sequence so that the first processing step would be carried
out on C2 by farnesyltransferase and palmitoylation on C1
would be carried out by palmitoyltransferase. In this case,
both geranylgeranyl groups found on wild-type Rab6 are
replaced, the C1 with palmitate and the C2 with farnesyl. In
addition, three Rab proteins were designed to have single
prenoid groups at the C terminus. The CXC motif was
replaced either with a CAAX sequence to generate a farne-
sylated Rab protein or with a CAAL sequence to generate a
singly geranylgeranylated Rab protein. Certain Rab proteins
terminate in a C1C2 motif which is geranylgeranylated by
GGTase II but probably only on C1, since C2 is not methy-
lated (42, 50). We therefore constructed a Rab6 protein with
a C1C2 motif in place of the wild-type C1XC2 sequence to
compare it with the CAAL mutant and hence address
whether methylation of the C terminus has any consequence
for localization and function of Rab proteins. The structures
of these mutant Rab proteins are summarized in Table 1,
which lists the actual amino acid sequences used in con-
structing the different C-terminal motifs. It should be noted
that only the C-terminal motifs of Rab6 are changed in each
case, and therefore all of the mutant proteins contain the
complete wild-type Rab6 sequence upstream of the CXC
motif. In addition, since Rab6 is expressed at a high level in
most mammalian cells (22), a duplicate set of constructs with
N-terminal Myc epitope tags (1) was made to allow discrim-
ination between endogenous and mutant Rab6 proteins dur-
ing immunolocalization.
Rab6 C-terminal mutants are processed in vitro and in vivo.
We have previously cloned CKCVLS, CKCCIL, CVLS,
and CCIL sequences from wild-type Ras and a mutant Ras
onto heterologous proteins and confirmed that they are
processed as described in Table 1 (25, 34). However, we
wished to verify that the expected processing events would
occur when these sequences were cloned onto a different
Ras-related protein, Rab6. First, to confirm that the mutant
Rab6 proteins were prenylated as predicted, the cDNAs
were cloned into pGEM vectors, and mRNA was tran-
scribed and translated in vitro in a nuclease-treated rabbit
reticulocyte lysate labelled with [3H]mevalonic acid (26). An
analysis of the radiolabelled prenoids attached to the pro-
teins showed that the RabCSC (wild type), RabCC, and
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TABLE 1. Summary of C-terminal mutant Rab6 proteins and their expected posttranslational modifications
C-terminal motif Processing bya: C-terminal structureb
Actualc Substrated Frase GGTase I GGTase II Protease Methylase PaImTase C1 C2 Methyl
CSC C1XC2 + + GG GG +
CC C1C2 + GG 0 0
CVLS C2AAX + + + 0 F +
CCILu C2AAL + + + 0 GG +
CKCVLS C1XC-2AAX + + + + Palm F +
CKCCIL C1xC2AAL + + + + Palm GG +
a +, the motif is expected to be processed by the enzyme(s) indicated. FTase, Farnesyltransferase; PalmTase, palmitoyltransferase.
b The fully processed C-terminal structure following modification. GG, geranylgeranylation; F, farnesylation; Palm, palmitoylation. The transferases which
carry out these lipid modifications are denoted by the suffix "Tase" and are described in the text.
c The actual motifs which replaced the wild-type C-terminal sequence.
d C1 and C2, the key cysteine residues which are modified by the prenyl- and palmitoyltransferases as discussed in the text.
I Although the CCIL motif has a Cys residue in what is the A1 position of the CAAL consensus sequence, it can still serve as a substrate for GGTase I (25,
37, 42).
RabCCIL proteins were geranylgeranylated, while the Rab-
CVLS protein was famesylated.
To further investigate in vivo posttranslational processing,
wild-type and mutant Rab6 proteins were transiently ex-
pressed in COS1 cells. The transfected cells were pulse-
labelled with [35S]methionine, chased in normal medium for
6 h, and lysed in Triton X-114. The aqueous and detergent-
enriched phases were immunoprecipitated with an anti-Rab6
serum (22). Figure 1 shows that all of the C-terminal mutant
Rab6 proteins were processed in COS1 cells. In each case,
30 to 50% of the labelled Rab protein chases from a slower-
migrating, aqueous-partitioning form into a faster-migrating,
prenylated, detergent-partitioning form. Interestingly, the
RabCC was processed efficiently, showing that Rab6 con-
tains the appropriate additional protein sequences or confor-
mation to permit processing of CC and CXC motifs. A
similar result was recently obtained with Rab2 (35). The
extent of processing of the various C-terminal mutant pro-
teins was similar to that of the wild-type protein (Fig. 1). The
extent of processing with CAAX/L motifs on the C terminus
of Rab6 was slower, however, than the extent to which these
motifs were processed when cloned onto the C terminus of
the heterologous protein, protein A. When COSi cells
overexpressing the C-terminal mutant Rab6 proteins were
labelled with [ H]palmitate, only RabCKCCIL and RabCK-
CVLS proteins incorporated label (Fig. 1). Rab6, RabCC,
and RabCCIL proteins were then expressed in COS1 cells
and labelled for 18 h with [methyl-3H]methionine. A vapor-
phase equilibration assay (16) showed that Rab6 and Rab-
CCIL were methyl esterified whereas RabCC was not.
WT CC CCIL CKCCIL CVLS CKCVLS
A D p A D p A D p A D p A D p A D p
FIG. 1. COS1 cells transiently expressing the Rab6 C-terminal
mutants described in Table 1 were pulse-labelled for 10 min with
[35S]methionine and chased for 6 h with cold methionine. Cells were
lysed in Triton X-114, the lysates were partitioned, and the aqueous
phase (A) and detergent phase (D) were separated. An aliquot of
cells from each transfection was also labelled with [3H]palmitic acid
(p). Samples were immunoprecipitated with anti-Rab6 antibodies,
resolved by SDS-PAGE, and fluorographed. The 35S-labeled lanes
(A and D) are overnight exposures, and the 3H-labeled lanes are
2-week exposures.
Taken together, these data from a combination of well-
validated in vitro and in vivo assays are fully consistent with
the modifications predicted for each of the mutants in Table
1. Essentially identical results (not shown) were obtained
with the N-terminal Myc-tagged Rab constructs, in agree-
ment with earlier reports that this N-terminal addition does
not compromise the posttranslational processing of Ras-
related proteins (1).
Farnesylation alone is insufficient for targeting Rab6 to the
Golgi complex. The subcellular distribution of C-terminal
mutant Myc-tagged Rab6 proteins was investigated in COS1
cells. Cells were fractionated, and equal proportions of the
S100 and P100 fractions were resolved by SDS-PAGE and
Western blotted with 9E10, an anti-Myc monoclonal anti-
body. Figure 2A shows that 50% of the wild-type Rab6 and
mutant RabCC proteins were found in the P100 fraction.
Some 30% of the RabCCIL protein expressed in COS cells
was P100 associated, while the extent of membrane associ-
ation of the geranylgeranylated, palmitoylated RabCKCCIL
protein approached that of the wild type (Fig. 2A). By
contrast, the RabCVLS mutant fractionated completely in
the cytosolic S100 fraction, but 30% of the farnesylated and
palmitoylated RabCKCVLS protein bound to cellular mem-
A
B
WT CC CCIL CKCCIL CVLS CKCVLS
S P S P S P S P S P S P
mUa aI a A&
WT CC CCIL CKCCIL CVLS CKCVLS
A D A D A D A D A D A D
_ _ _ _M _._ _
FIG. 2. (A) COS1 cells expressing the Myc-tagged Rab6 mutant
proteins were fractionated into P100 (P) and S100 (S) fractions.
Equal proportions of all fractions were resolved by SDS-PAGE and
Western blotted with an anti-Myc monoclonal antibody. (B) COS1
cells expressing the Rab6 C-terminal mutants were pulse-labelled for
10 min with [3 S]methionine and chased for 24 h with cold methio-
nine. Lysates were prepared and analyzed as described in the legend
to Fig. 1. WT, wild type.
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748 BERANGER ET AL.
branes. Figure 2A also shows that for all of the Rab6 proteins
with CAAX/L motifs, two species with different electro-
phoretic mobilities were found in the S100 fraction. Both
partitioned into the aqueous phase of Triton X-114 except
with RabCVLS, in which case half of the fast-migrating
cytosolic form was detergent partitioning. A fast-migrating
hydrophilic form was not observed with the wild-type or the
RabCC mutant protein. Figure 2B shows that the fast-
migrating hydrophilic form of the RabCCIL, RabCKCCIL,
RabCVLS, and RabCKCVLS proteins is clearly apparent 24
h after the cells were pulse-labelled but is not visible after a
6-h cold chase (Fig. 1). This lower-molecular-weight hydro-
philic form may therefore represent either processed Rab
which has been deprenylated or, more probably, nonproc-
essed Rab which has undergone proteolysis. Hrycyna and
Clarke (33) recently described a cytosolic carboxypeptidase
which specifically recognizes proteins with unprocessed
C-terminal CAAX sequences. This or a related enzyme may
be responsible for proteolysing the unprocessed Rab pro-
teins which accumulate in the COS1 cells as a result of the
slower rate of processing of the CAAX/L motifs when
present at the C terminus of Rab6.
We next investigated the localization of the Myc-tagged
Rab6 proteins in MDCK cells by indirect immunofluores-
cence following microinjection of plasmid DNA. To study
only membrane-bound Rab6 protein, the MDCK cells were
permeabilized before fixation to wash out cytosolic soluble
forms. With this protocol, the staining pattern with 9E10 in
cells overexpressing Myc-tagged wild-type Rab6 was identi-
cal to that seen when endogenous Rab6 was visualized in
noninjected cells with an anti-Rab6 serum (Fig. 3). These
results demonstrate that the addition of a Myc epitope at the
N terminus does not affect the subcellular localization of
Rab6 protein and clearly show that overexpression of Rab6
in MDCK cells does not cause mislocalization by saturating
the Golgi complex. A previous report (2) suggesting aberrant
localization of overexpressed Rab6 did not take account of
the significant amount of nonprocessed protein. Figure 3 also
shows that despite different posttranslational modifications,
the RabCC, RabCCIL, RabCKCCIL, and RabCKCVLS
proteins all appeared to be localized to the Golgi complex.
The farnesylated RabCVLS protein, being soluble, was
washed out of the cells, although very faint nuclear staining
was evident (Fig. 3). In cells permeabilized after fixation,
however, the RabCVLS protein was visible diffusely
through the cytoplasm, consistent with its fractionation to
S100 fraction (Fig. 2A). To exclude the possibility that some
of the intracellular staining seen with the mutant proteins
was endosomal rather than in the Golgi complex, these
experiments were repeated in Swiss 3T3 cells which, unlike
MDCK cells, are sensitive to brefeldin A. Treatment with
brefeldin A causes the bulk of the Golgi complex to redis-
tribute into the endoplasmic reticulum (38a). Figure 4b
shows that brefeldin A treatment of Swiss 3T3 cells causes
complete disappearance of endogenous Rab6 staining. In
cells overexpressing Myc-tagged Rab6 (Fig. 4c and d),
juxtanuclear staining is lost and replaced with a diffuse
reticular staining. Exactly the same effect is seen in cells
expressing the Myc-tagged RabCC, RabCCIL, and RabCK-
CCIL proteins (Fig. 4e to j), consistent with these proteins
being Golgi complex localized to the same extent as the
Myc-tagged wild-type Rab6 protein. Fifty percent of cells
expressing Myc-tagged RabCKCVLS showed some persis-
tence of juxtanuclear staining following brefeldin A expo-
sure, although otherwise the extent and pattern of staining in
the RabCKCVLS-expressing cells matched that seen in cells
overexpressing Myc-tagged wild-type Rab6 (Fig. 4k and 1).
These data are consistent with the majority of the RabCK-
CVLS mutant being Golgi complex localized, although a
proportion may be mislocalized to another structure.
Golgi complex-targeting sequences of Rab6 are located
outside the C-terminal hypervariable domain. Figures 3 and 4
show that the palmitoylated and farnesylated RabCKCVLS
protein was targeted to the Golgi complex. This combination
of lipids has been shown previously to function as a plasma
membrane-targeting signal both for Ras and for heterologous
proteins (25, 34). One interpretation of these data is that
there are domains within Rab6 that prevent palmitoylated,
farnesylated Rab6 from localizing to the plasma membrane.
Since Chavrier et al. (14) have shown that the C-terminal
hypervariable domains of Rab5 and Rab7 are involved in
subcellular localization, we investigated whether this do-
main in Rab6 contains sequences which override the plasma
membrane-targeting function of the palmitic acid-prenoid
combination. A SpeI restriction site was introduced into
H-Ras at amino acid position 144 to correspond with a SpeI
site in Rab6 at amino acid 155. These are equivalent residues
because Rab6 has an extra 11 amino acids at the N terminus
when aligned with Ras. The C-terminal 45 amino acids of
Rab6 and H-Ras were then exchanged. This Rabl55-Ras
chimeric protein has a C-terminal CKCVLS motif but lacks
the Rab6 hypervariable domain. A geranylgeranylated form
of the Rab155-Ras chimera was also constructed by replac-
ing the CVLS sequence of Rabl55-Ras with a geranylgera-
nylated CCIL motif. The chimeric proteins were processed
as determined by Triton X-114 phase partitioning, both
incorporated label from [3H]palmitic acid, and both were
P100 associated (Fig. 5 and data not shown). Immunofluo-
rescence studies in MDCK cells expressing these chimeric
Rabl55-Ras proteins now showed staining of both plasma
membrane and Golgi complex (Fig. 6), consistent with the
notion that the Rab6 hypervariable region was preventing
plasma membrane localization. To confirm that palmitic acid
was responsible for the partial plasma membrane localiza-
tion of the Rabl55-Ras chimeric protein, we removed the
cysteine acylation sites upstream of the C-terminal prenyla-
tion motif in the geranylgeranylated Rab155-Ras chimera
by introducing serine mutations. These mutations do not
interfere with prenylation but block palmitoylation. The
geranylgeranylated, nonpalmitoylated Rab155-Ras chimera
FIG. 3. MDCK cells were microinjected with plasmid DNA and analyzed 18 h later. Cells were permeabilized with saponin and washed
before fixation to remove all soluble proteins. (a) MDCK cells stained with an affinity-purified anti-Rab6 antibody (22). Endogenous Rab6 is
well expressed and shows the localization of the Golgi complex. (b) MDCK cells microinjected with Myc-tagged Rab6 and stained with an
anti-Myc antibody. The localization of this protein is identical to that seen in panel a. There is no staining of any intracellular structure with
this antibody in noninjected MDCK cells (not shown). (c) MDCK cells injected with Myc-tagged RabCC. (d) MDCK cells injected with
Myc-tagged RabCCIL. (e) MDCK cells injected with Myc-tagged RabCKCCIL. (f) MDCK cells injected with Myc-tagged RabCKCVLS. (g)
MDCK cells injected with Myc-tagged RabCVLS. The cells in panels c to f were stained with the anti-Myc antibody 9E10. Note that the Golgi
complex staining in panels c to f is identical to that seen with wild-type Rab6 shown in panels a and b. No Golgi complex staining is seen in
cells microinjected with Myc-tagged RabCVLS (g).
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PRENYLATION AND GOLGI APPARATUS TARGETING OF Rab6 751
FIG. 4. Swiss 3T3 cells show redistribution of the Golgi complex into the endoplasmic reticulum upon exposure to brefeldin A (38a). (a,
c, e, g, i, and k) Swiss 3T3 cells that have been microinjected with plasmid DNA and 18 h later permeabilized, washed, and fixed; (b, d, f,
h, j, and 1) cells prepared in the same manner except that they were treated with brefeldin A immediately before permeabilization; (a and b)
endogenous Rab6 stained with antiRab6; (c and d) cells injected with Myc-tagged Rab6; (e and f) cells injected with Myc-tagged RabCC; (g
and h) cells injected with Myc-tagged RabCCIL; (i and j) cells injected with Myc-tagged RabCKCCIL; (k and 1) cells injected with Myc-tagged
RabCKCVLS. The cells in panels a and b were stained with affinity-purified anti-Rab6. Note that brefeldin treatment causes complete loss
of the juxtanuclear staining. The cells in panels c to 1 were stained with anti-Myc antibody. Brefeldin causes complete loss of juxtanuclear
staining in cells expressing Rab6, RabCC, RabCCIL, and RabCKCCIL, confirming that these proteins are exclusively in the Golgi complex.
Of the cells expressing RabCKCVLS, 50% also show complete loss of juxtanuclear staining upon brefeldin treatment; the remainder show
loss of the majority of such staining. This finding indicates that while most of RabCKCVLS is Golgi complex associated, a small amount may
be endosomal.
fractionated in the P100 fraction (Fig. 5), and immunolocal-
ization in MDCK cells showed it to be exclusively in the
Golgi complex (Fig. 6), although the staining was less intense
and slightly more diffuse than with full-length Rab6 (compare
with Fig. 3). Preliminary experiments in Swiss 3T3 cells
suggest that this staining is brefeldin A sensitive. As an
additional control, we investigated the localization of a
full-length, Myc-tagged H-Ras protein with identical C-ter-
minal modifications to the Golgi complex-localized RabiSS-
Ras chimera with respect to geranylgeranylation and no
palmitoylation. This mutant H-Ras protein was P100 associ-
ated, but as shown in Fig. 6, it did not localize to the Golgi
complex or plasma membrane. In addition to demonstrating
the key role of palmitic acid in plasma membrane targeting,
these results suggest that Golgi complex-targeting sequences
of Rab6 are located, at least in part, in the N-terminal 155
amino acids.
The effector domain of Rab6 is required for Golgi localiza-
tion. To further define the N-terminal targeting sequence, we
constructed a more extensive series of chimeras in which
various amounts of H-Ras sequence were used to replace
homologous sequences at the N terminus of the nonpalmi-
toylated, geranylgeranylated RabiSS-Ras chimera (Fig. 7).
All of these chimeras were stably expressed and membrane
associated when analyzed in COS1 cells, but as summarized
in Fig. 7, none showed any affinity for the Golgi complex
when analyzed by immunofluorescence in MDCK cells,
implying that the N-terminal 71 amino acids of Rab6 are
required for Golgi complex localization of the Rab155-Ras
chimera. To more precisely map potential sites of interaction
with a Golgi complex protein, we next replaced short se-
quences in the N-terminal 71 amino acids of full-length
wild-type Rab6 with homologous sequences from Ras. We
argued that loops predicted to be on the outside of the Rab6
protein would be the domains of the protein most likely to be
involved in binding to the Golgi complex. Also, in an attempt
to maintain as normal a conformation of the mutated protein
as possible, we replaced complete loops of Rab6 with the
corresponding complete loops of Ras. Therefore, the effec-
tor domain of Rab6 (loop 2) was replaced with the Ras
effector domain (to give Rab-L2Ras), and loop 3 of Rab6 was
replaced with loop 3 of Ras (to give Rab-L3Ras) (Fig. 7). A
third chimera (Rab-L2+L3Ras) in which both loops were
replaced with Ras sequence was constructed. All three
chimeras were processed to the same extent as wild-type
Rab6 in COS cells and were membrane associated (data not
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A and RabCKCCIL (Fig. 9A). Expression of the farnesylated
Rab6 protein RabCVLS did not complement ypt6, but ex-
155 pression of the palmitoylated and famesylated mutant
iniiiiiiiii_ CVLS GOLGI + PM RabCKCVLS protein did complementypt6 (Fig. 9A). Thus,
the ability of the C-terminal mutant Rab6 proteins to com-
1_11 CCIL GOLGI + PM plement the ypt6 temperature-sensitive growth defect corre-lates precisely with their ability to localize to the Golgi
-35 CCIL GOLGI complex in mammalian cells. Notably, expression of the
Rabl55-Ras protein (chimera a in Fig. 5), which contains the
L SS CCIL -- H-Ras hypervariable C-terminal domain instead of the cor-responding Rab6 region, functioned as well as wild-type
_cCXC GOLGI Rab6 to complement ypt6 (Fig. 9A).While performing the replica-plating assay, we noted that
CVLS________________PMgrowth at the higher temperature ofypt6 mutants expressingr---CVLS PMRabCCIL was not as rapid as that ofypt6 mutants expressing
wild-type Rab6, RabCC, or RabCKCCIL. To confirm this
observation, we performed growth assays in liquid culture
B for ypt6 mutants expressing either wild-type Rab6, RabCC,
a b C d or RabCCIL. Following a shift to 37.5°C, ypt6 mutants not
expressing any Rab6 protein ceased growth after approxi-
s P s P s P s P mately 2 h (Fig. 9B). In contrast, ypt6 mutants which
- _ expressed either wild-type Rab or RabCC continued to grow
exponentially until reaching saturation (Fig. 9B). An inter-
mediate growth response was observed with ypt6 mutants
expressing RabCCIL. After 2 h, these cells grew more;.5. (A) The Rab-Ras chizmeric proteins (a to c) have the slwl thn.tuat xrssn idtp 6ofinal 155 amino acids of Rab6 (e) fused to the C-terminal 45 slowly than ypt6 mutants expressing wild-type Rab6 or
acids of H-Ras (f). Rab6 has an extra 11 amino acids at the N RabCC, eventually reaching a saturation density close to
Lus when aligned with H-Ras, and therefore the residue that obtained by ypt6 mutants expressing wild-type Rab6
lent to 155 in Rab6 is 144 in H-Ras. The C-terminal sequences (Fig. 9B and data not shown). Thus, while RabCCIL can
chimeras are shown; chimera a is palmitoylated and farnesy- function in yeast cells, it appears to function less well than
chimera b is palmitoylated and geranylgeranylated, and chi- Rab6 itself or RabCC.
c and control protein d are only geranylgeranylated because To confirm that the growth defect with RabCCIL and the
nes 181 and 184 in the H-Ras hypervariable domain have been inability of RabCVLS to complement ypt6- was not simply
ed to serines (SS). The localization data shown in Fig. 6 are due to a problem with expression, we investigated the
arized. PM, plasma membrane; --, no binding to the Golgi steady-state level of expression in each of the transformants.[ex or plasma membrane. (B) COS1 cells expressing chimeras Figure lvof enpron at thepe rm ants.
and the H-Ras geranylgeranylated, nonpalmitoylated control Figure 9C shows that when grown at the permissive temper-
era d) were fractionated into S100 (S) and P100 (P) fractions, ature, each of the transformed strains expressed a Myc-
he same proportion of each was Western blotted with the tagged Rab protein. The steady-state levels of expression of
lyc monoclonal antibody 9E10. All of these proteins bind to all of the mutant proteins were comparable (Fig. 9C).
oranes.
shown and Fig. 7). The wild-type CXC C terminus was
present in these chimeras, which indicates that the confor-
mation of the mutant proteins was sufficiently close to that of
a wild-type Rab protein to allow processing by GGTase II.
Interestingly, an analysis of the localization of these proteins
in MDCK cells showed that the Rab6 effector domain was
essential for Golgi complex targeting. In Fig. 8, it is clear
that Rab-L2Ras and Rab-L2+L3R show very weak or no
Golgi complex staining, while Rab-L3Ras shows wild-type
Golgi complex staining. All proteins were expressed to the
same extent in MDCK cells, as shown by the equivalent
staining of cells fixed before permeabilization (Fig. 8).
Farnesylation alone does not allow Rab6 to complement the
yeast ypt6 mutation. The ability of the C-terminal mutant
Rab6 proteins to function in vivo was analyzed in yeast cells.
The YPT6 gene encodes a Rab6 homolog, and disruption of
this gene impairs growth at higher temperatures (31, 47a).
Complementation of this temperature-sensitive growth de-
fect was tested following transformation of a ypt6 null
mutant with plasmids which drive expression of either
wild-type or C-terminal mutant Rab6 proteins. In a replica-
plating assay, expression of the wild-type Rab6 protein
restored growth at high temperature, as did expression of the
other geranylgeranylated Rab6 proteins RabCC, RabCCIL,
DISCUSSION
The majority of Ras-related proteins terminate in cysteine-
containing C-terminal motifs that direct prenylation with C15
farnesyl or C20 geranylgeranyl. It is striking that whereas
Ras is farnesylated, most other Ras-related proteins are
geranylgeranylated. The role of farnesylation coupled with a
second signal such as palmitoylation or the presence of
several basic residues in targeting Ras to the plasma mem-
brane has been well characterized (28, 30), but the role that
geranylgeranylation plays in membrane targeting and the
biological function of other Ras-related proteins have not to
date been carefully addressed. In this study, we have exam-
ined whether geranylgeranylation is absolutely required for
the localization and biological function of the Ras-related
protein Rab6 and mapped other domains in this protein that
are required for its subcellular targeting. By making use of
the known recognition sequences of the three characterized
prenoid transferases and also the acyltransferase that palm-
itoylates the Ras proteins, we were able to replace the
wild-type doubly geranylgeranylated, methylated C terminus
of Rab6 with five different lipid combinations.
Although wild-type Rab6 is prenylated with two gera-
nylgeranyl groups, we found that replacement of one of
these geranylgeranyl groups with an acyl group, palmitic
acid, did not affect its subcellular localization. Moreover, a
a
b
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PRENYLATION AND GOLGI APPARATUS TARGETING OF Rab6 753
FIG. 6. MDCK cells were microinjected with expression plasmids. After 24 h, the cells were permeabilized with saponin, washed, and
fixed. Rabl55-Ras chimeric proteins and the Ras control proteins (a to d in Fig. 5A) were visualized by immunofluorescence in a confocal
microscope. The primary antibody used was the anti-Myc monoclonal antibody 9E10. (a) Rabl55-Ras chimera a modified by palmitoylation
and farnesylation; (b) Rabl55-Ras chimera b modified by palmitoylation and geranylgeranylation; (c) Rabl55-Ras chimera c modified by
geranylgeranylation only; (d) H-Ras modified by geranylgeranylation only. In panels a and b, staining of both the plasma membrane and the
Golgi complex is evident. Golgi complex staining alone is evident in panel c, although this staining is less intense than that seen with
Myc-tagged Rab6 (compare with Fig. 3b). No plasma membrane staining nor Golgi complex staining is seen in panel d, although expression
of the protein was confirmed in cells fixed before permeabilization (not shown).
single geranylgeranyl group also proved sufficient to localize
the RabCCIL protein to the Golgi complex. This Golgi
complex localization was unaffected by methylation of the C
terminus, since the methylated RabCCIL protein and the
nonmethylated RabCC protein were both correctly targeted.
Replacement of both geranylgeranyl groups with a single
farnesyl moiety, however, rendered Rab6 cytosolic. Inter-
estingly, the combination of palmitoylation plus famesyla-
tion restored Rab6 to the Golgi complex. One interpretation
of these data is that a minimum degree of hydrophobicity of
the C terminus of a Rab protein is required for its membrane
association which cannot be provided by an isolated farnesyl
group. In support of this hypothesis, it has recently been
estimated that the hydrophobicity of geranylgeranyl is an
order of magnitude greater than that of either famesyl or
palmitoyl (5). These data correlate with our previous obser-
vations that geranylgeranylated Ras proteins bind with sig-
nificantly higher affinity to cellular membranes than famesy-
lated Ras proteins do and that the avidity of membrane
binding of a palmitoylated and famesylated Ras protein is
similar to that of a geranylgeranylated protein (25, 30).
Taken together, these data suggest that palmitoylation in-
creases the hydrophobicity of a farnesylated Rab6 C termi-
nus sufficiently to permit membrane binding. It is evident
from these experiments that a single geranylgeranyl group is
sufficient for the subcellular localization of Rab6, raising the
question of whether the second geranylgeranyl moiety
present in Rab6 and other CXC-containing Rab proteins
serves some other function.
Although Rab proteins are all prenylated with one or two
geranylgeranyl groups, they are localized to different subcel-
lular structures. Thus, while lipid modification is required for
the membrane binding of Rab proteins, other features are
clearly necessary for specific subcellular targeting. In the
Ras proteins, these additional sequences comprise a palmi-
toylation site or a polylysine domain which is located adja-
cent to the CAAX motif in the C-terminal hypervariable
domain. The targeting sequences of other Ras-related pro-
teins have been thought to be similarly situated. Evidence
for this has recently been provided by Chavrier et al. (14),
who showed that exchanging the hypervariable domains of
Rab5 and Rab7 switched their specific subcellular localiza-
tion. We found in this study, however, that when the
hypervariable domain of Rab6 was replaced with that of a
geranylgeranylated, nonpalmitoylated Ras protein, the chi-
meric protein remained in the Golgi complex. The full-length
geranylgeranylated, nonpalmitoylated mutant Ras protein,
which provided the C-terminal sequences for this chimera,
showed no affinity for the Golgi complex or plasma mem-
brane, in agreement with previous data (25). However, the
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FIG. 7. (A) Structures of the Rab-Ras chimeras used to map the involvement of the Rab6 effector domain in Golgi complex targeting. The
C-terminal motif present, either CCIL or CXC, is given for each chimera. Note that the Ras sequence used to construct these chimeras
(indicated by *) has a CCIL C-terminal motif and has had the palmitoylation sites Cys-181 and Cys-184 mutated to Ser to prevent
palmitoylation and thus plasma membrane localization of the chimeras. The numbering used refers to Rab6 amino acids; for the homologous
amino acid in Ras, subtract 11 from the Rab6 residue number (see text). All of the chimeras have an N-terminal Myc tag. Golgi complex
localization was investigated by immunofluorescent staining using the anti-Myc antibody 9E10. All of the localization data are summarized
here, and selected confocal images are shown in Fig. 8. + + +, wild-type Golgi complex staining; +, weak Golgi complex staining (as seen
in Fig. 6c). (B) The Rab-L2 Ras, Rab-L3Ras, and Rab-L2+L3Ras proteins have CXC C-terminal motifs and are processed to the same extent
as wild-type Rab6 in COS cells (not shown). COS cells expressing these proteins were fractionated into S100 (s) and P100 (p) fractions, and
equal proportions of all fractions resolved by SDS-PAGE and immunoblotted with the anti-Myc antibody 9E10. All of these chimeras are
extensively membrane bound.
subcellular localization of the Rabl55-Ras chimera was
critically dependent on the specific C-terminal lipid modifi-
cation. A palmitic acid moiety with either a farnesyl or
geranylgeranyl isoprenoid localized the Rab155-Ras protein
both to the plasma membrane and to the Golgi complex. This
finding illustrates the critical role of palmitic acid in targeting
proteins to the plasma membrane, which has already been
demonstrated for Ras and certain heterologous proteins (25,
34). However, the plasma membrane-targeting effect of
palmitic acid was overcome in presence of the C-terminal
hypervariable domain of Rab6, since palmitoylated and
farnesylated, as well as palmitoylated and geranylgerany-
lated, forms of Rab6 were found exclusively in the Golgi
complex. One explanation for this finding is that the hyper-
variable domain of Rab6 may enhance the avidity of Golgi
complex association by stabilizing the interaction of the N
terminus with a Golgi complex receptor protein. The immu-
nofluorescence data are consistent with this view because
the Golgi complex staining observed with the nonpalmitoy-
lated and geranylgeranylated Rabl55-Ras chimera was less
intense than that seen with full-length Rab6, suggesting that
some P100-associated Rabl55-Ras protein was washed out
of the cells prior to fixation. Alternatively, the hypervariable
domain of Rab6 may interact with proteins that are not
directly concerned with subcellular targeting but can indi-
rectly prevent a C-terminal palmitoyl group binding to
plasma membrane.
The sequence in N-terminal 155 amino acids of Rab6 that
is required for Golgi complex localization mapped to the
effector domain. If the effector domain of Rab6 is required
for binding to Rab6-GAP, as is the case with Ras, there is the
interesting possibility that the Golgi complex docking pro-
tein for Rab6 is Rab6-GAP itself. This predicts that Rab6-
GAP should colocalize with Rab6 to the Golgi. Recently,
Gyp6p, a specific GAP for Ypt6p, the yeast homolog of
Rab6, has been cloned (47a), but the subcellular localization
of Gyp6p has not been reported. It could be argued that the
Rab-L2Ras chimeras mislocalize because they are fixed in
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PRENYLATION AND GOLGI APPARATUS TARGETING OF Rab6 755
FIG. 8. MDCK cells were microinjected with Rab-L2Ras (a and b), Rab-L3Ras (c and d), or Rab-L2+L3 (e and t) plasmids and examined
18 h later. The cells in panels a, c, and e were permeabilized and washed before fixation. The Rab-L3 chimera (c) shows wild-type Golgi
complex staining, while both of the chimeras with the effector domain of Ras substituting for the Rab6 effector domain show barely detectable
Golgi staining. Panels b, d, and f show cells fixed before permeabilization and washing to verify that the level of expression of each of these
chimeras in MDCK cells was similar. All staining was carried out with the anti-Myc antibody 9E10.
the GTP-bound form as a result of not interacting with
Rab6-GAP. However, we do not think that this is likely
because Rab6 which is constitutively GTP bound as a result
of a G23V substitution is localized normally to the Golgi
(21a). We attempted to target Ras to the Golgi complex by
replacing homologous Ras sequences with the effector and
hypervariable domains of Rab6 together with a CCIL motif.
Unfortunately, this chimera was unstable. Thus, while we
have shown that the effector domain of Rab6 is essential for
localization and that the hypervariable domain enhances
Golgi complex association, we cannot conclude that these
sequences are fully sufficient for localization.
Our data on Rab6 show that the subcellular targeting of
Rab proteins is more complex than previously thought, since
in addition to lipid modifications, both N-terminal and C-ter-
minal domains appear to be involved. These data may also
be of relevance to another Ras-related protein, Rapl, which
is localized in the Golgi complex (4). This protein possesses
a C terminus with a CAAL box and a polylysine domain
which can target heterologous proteins to the plasma mem-
brane (25), suggesting that the Golgi complex localization of
Rapl involves other domain(s) which override the C-termi-
nal plasma membrane-targeting motif.
We also addressed whether, in addition to their role in
membrane binding, lipid-modifying groups and C-terminal
sequences were important for the biological activity of Rab6.
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FIG. 9. (A) Replica-plating assay of growth at high temperature of yeast cells containing a mutation in the Rab6 homolog (ypt6::LEU2) and
plasmids which express wild-type or mutant Rab6 C-terminal mutant proteins. The Rab6 C-terminal mutants are described in Table 1, and
the Rab-Ras construct is chimera a in Fig. 4. Theypt6::LEU2 mutation blocks growth at 37.5'C when the cells are grown in synthetic medium
and is suppressed by expression of mammalian Rab6 and all of the C-terminal mutants of Rab6 except RabCVLS. (B) Growth in liquid cultures
following a shift to 37.5°C of yeast cells containing a mutation in the Rab6 homolog (ypt6::LEU2) and plasmids which express no gene (open
circles), wild-type Rab6 (closed circles), or Rab6 C-terminal mutant protein RabCC (open triangles) or RabCCIL (open squares). (C) Yeast
cells transformed by each of the Rab6 mutant and wild-type plasmids were grown at the permissive temperature. Lysates were prepared, and
40 ,ug of total protein was acetone precipitated, resolved by SDS-PAGE, and Western blotted with the anti-Myc antibody 9E10. Lanes: a,
RabCC; b, RabCKCCIL; c, RabCCIL; d, RabCKCVLS; e, Rabl55-Ras (with a CKCVLS C terminus); f, Rab6 wild-type C terminus; g,
RabCVLS; h, yeast cells transformed with an empty vector.
To this end, we used S. cerevisiae as a model system since
it contains a gene, YPT6, which is highly homologous to rab6
(31, 47a). We found that the ability of mutant Rab6 proteins
to functionally complement the growth defect at higher
temperatures associated with YPT6 deletion correlates di-
rectly with the correct targeting of these proteins to the Golgi
complex in mammalian cells. Thus, in this assay, farnesyla-
tion alone as a C-terminal lipid modification is unable to
render the Rab6 protein biologically active. This is the first in
vivo demonstration of the relevance of specific prenoid
modification to Rab function and also highlights the impor-
tance of localization to Rab function. Interestingly, the
correlation between correction of temperature-sensitive phe-
notype and Golgi complex localization extended to the
Rab-Ras chimeric proteins which lack the hypervariable
domain of Rab6. These data indicate that at least in yeast
cells, the hypervariable domain of Rab6 is not required for
biological activity. A subtle difference was observed be-
tween the methylated RabCCIL and nonmethylated RabCC
proteins that were prenylated with a single geranylgeranyl
group. While both of these mutant Rab6 proteins localized
normally in the Golgi complex and both corrected the
temperature-sensitive growth defect in S. cerevisiae, it was
clear that yeast cells expressing the methylated protein grew
significantly more slowly than those expressing the nonmeth-
ylated protein. It is possible that the interaction of Rab6 with
a protein essential for biological activity but not for Golgi
complex localization may be favored by a negatively charged
C terminus in the context of a single geranylgeranyl group. It
is worth noting that Rho and Rac proteins that are gera-
nylgeranylated, AAX proteolysed, but nonmethylated after
processing in the presence of an inhibitor of methyltrans-
ferase bind more extensively to RhoGDI than the fully
processed methylated proteins do (27). We are currently
investigating to what extent the mutant Rab6 proteins de-
scribed here interact with RabGDI, a protein which func-
tions in the recycling of Rab proteins between donor and
acceptor membranes (3).
Taken together, our results describe the respective roles
of posttranslational modifications and targeting sequences in
the subcellular localization and biological function of a Rab
protein. The mechanisms that lead to the preferential asso-
ciation of Rab proteins with specific membranes and the
identification of the components with which they interact
remain to be unravelled.
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